Trial Profile
Prospective multi center observational study for ocular side-effects by TS-1
Status:
Active, no longer recruiting
Phase of Trial:
Phase IV
Latest Information Update: 25 Nov 2019
Price :
$35
*
At a glance
- Drugs Gimeracil/oteracil/tegafur (Primary)
- Indications Cancer
- Focus Adverse reactions
- 22 May 2018 Status changed from recruiting to active, no longer recruiting.
- 08 Jul 2014 New trial record